Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
BioViotica
Obscurolide A1
145
CHF
CHF 145.00
In stock
BVT-0287-M0011 mgCHF 145.00
Product Details | |
---|---|
Synonyms | (E)-4-((2-(3-Hydroxybut-1-en-1-yl)-5-oxotetra-hydrofuran-3-yl)amino)benzoic acid |
Product Type | Chemical |
Properties | |
Formula |
C15H17NO5 |
MW | 291.3 |
CAS | 144397-99-9 |
Source/Host Chemicals | Isolated from Streptomyces viridochromogenes. |
Purity Chemicals | ≥98% (HPLC) |
Appearance | Off-white to pale yellow powder. |
Solubility | Soluble in methanol, DMSO or acetone. |
Identity | Determined by 1H-NMR. |
Declaration | Manufactured by BioViotica. |
InChi Key | IZSWILLJDXDGDJ-FARCUNLSSA-N |
Smiles | CC(O)\C=C\C1OC(=O)CC1NC1=CC=C(C=C1)C(O)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability |
Stable for at least 1 year after receipt when stored at -20°C. After reconstitution protect from light at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Weak phosphodiesterase inhibitor.
Product References
- Metabolic products of microorganisms. 261. Obscurolides, a novel class of phosphodiesterase inhibitors from streptomyces. I. Production, isolation, structural elucidation and biological activity of obscurolides A1 to A4: H. Hoff, et al.; J. Antibiot. 45, 1096 (1992)